NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Nichols E; Institute of Medicine (US) Roundtable for the Development of Drugs and Vaccines Against AIDS. Expanding Access to Investigational Therapies for HIV Infection and AIDS: March 12–13, 1990 Conference Summary. Washington (DC): National Academies Press (US); 1991.
Expanding Access to Investigational Therapies for HIV Infection and AIDS: March 12–13, 1990 Conference Summary.
Show details- HAROLD S. GINSBERG (Co-chair), Eugene Higgins Professor of Medicine and Microbiology, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York
- SHELDON M. WOLFF (Co-chair), Physician-in-Chief, New England Medical Center, and Endicott Professor and Chairman, Department of Medicine, Tufts University School of Medicine, Boston
- DAVID W. BARRY, Vice President of Research, The Wellcome Research Laboratories, Burroughs Wellcome Co., Research Triangle Park, North Carolina
- JAMES S. BENSON, Acting Commissioner, Food and Drug Administration, Rockville, Maryland
- DONALD S. BURKE, Colonel, Medical Corps, U.S. Army, and Director, Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, Maryland
- BRUCE A. CHABNER, Director, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- MAX D. COOPER, Investigator, Howard Hughes Medical Institute, and Professor of Medicine, Pediatrics, and Microbiology, University of Alabama, Birmingham
- MARTIN DELANEY, Co-Executive Director and President, Project Inform, San Francisco
- DANIEL DEYKIN, Chief, Cooperative Studies Program. Veterans Administration Medical Center, Boston
- R. GORDON DOUGLAS, Senior Vice President, Medical and Scientific Affairs, Merck Sharp & Dohme International, Rahway, New Jersey
- ANTHONY S. FAUCI, Associate Director for AIDS Research, National Institutes of Health, and Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
- GERALD FRIEDLAND, Professor of Medicine, Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, The Bronx, New York
- L. PATRICK GAGE, Executive Vice President, Genetics Institute, Inc., Cambridge, Massachusetts
- PETER BARTON HUTT, Partner, Covington & Burling, Washington, D.C.
- JAY C. LIPNER, Partner, Silverstein Langer Lipner & Newburgh, New York, New York
- DAVID W. MARTIN, JR., Vice President, Research and Development, The Dupont Merck Pharmaceutical Company, Wilmington, Delaware
- CATHERINE M. WILFERT, Professor of Pediatrics and Microbiology, Department of Pediatrics, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
STAFF
- ROBIN WEISS, Project Director and Director, AIDS Activities
- SHARON BARATZ, Research Associate
- RICHARD BERZON, Staff Officer
- GAIL SPEARS, Administrative Assistant
- ROUNDTABLE FOR THE DEVELOPMENT OF DRUGS AND VACCINES AGAINST AIDS - Expanding Ac...ROUNDTABLE FOR THE DEVELOPMENT OF DRUGS AND VACCINES AGAINST AIDS - Expanding Access to Investigational Therapies for HIV Infection and AIDS
Your browsing activity is empty.
Activity recording is turned off.
See more...